Pcn122 - Drivers for Different Treatment Cost Estimations Across Hta Bodies

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Trouble With Cost-Utility HTA Bodies: They Should Determine the Price Not React to It

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Reimbursement Decision Landscape for Orphan Drugs Across Six Hta Agencies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Ledipasvir / Sofosbuvir for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pnd99 - Cystic Fibrosis Therapies - Key Drivers Behind Differing Hta Decisions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost Savings in Wastewater Treatment Processes: The Role of Environmental and Operational Drivers

Water Resources Management
CivilWater ScienceTechnologyStructural Engineering
2017English

Global Scale Benefit-Cost Analysis of Coastal Flood Adaptation to Different Flood Risk Drivers

2019English

Tracking Pedestrians Across Multiple Microcells Based on Successive Bayesian Estimations

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2014English

Cost-Effectiveness of Different Treatment Modalities for Seasonal Allergic Rhinitis in Japan

Laser Therapy
SurgeryBiomedical Engineering
2008English

Non-Tariff Measure Estimations in Different Impact Assessments

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy